Baxter International Inc. (NYSE:BAX) belonging to the Medical sector has surged 0.81% and closed its last trading session at $47.2.
The company reported its last EPS on 9/30/2016 and is expected to report its next EPS on Oct 25 BMO. Currently, the stock has a 1 Year Price Target of $52.83.
The consensus recommendation, according to Zacks Investment research, is 2.66. The scale runs from 1 to 5 with 1 recommending Strong Buy and 5 recommending a Strong Sell. The Stock had a 2.78 Consensus Analyst Recommendation 30 Days Ago, whereas 60 days ago and 90 days ago the analyst recommendations were 2.94 and 2.94 respectively.
Baxter International Inc. on 9/30/2016 reported its EPS as $0.56 with the analysts projecting the EPS of the stock as $0.45. The company beat the analyst EPS Estimate with the difference of $0.11. This shows a surprise factor of 24.4%.
Many analysts have provided their estimated foresights on Baxter International Inc. Earnings, with 14 analysts believing the company would generate an Average Estimate of $0.52. Whereas they predicted High and Low Earnings Estimate as $0.55 and $0.49 respectively. While in the same Quarter Previous year, the Actual EPS was $0.43.
Analysts are also projecting an Average Revenue Estimate for Baxter International Inc. as $2.66 Billion in the Current Quarter. This estimate is provided by 13 analysts. The High Revenue estimate is predicted as 2.67 Billion, while the Low Revenue Estimate prediction stands at 2.64 Billion. The company’s last year sales total was 2.6 Billion.
For the Current Quarter, the growth estimate for Baxter International Inc. is 20.9%, while for the Next Quarter the stock growth estimate is 22.2%. In the past 5 years, the stock showed growth of -15.71% per annum. While for the next 5 years, the growth estimate is 13.8%.
The Company got Initiated by Wells Fargo on 13-Oct-16 to Outperform.
Insider Trades for Baxter International Inc. show that the latest trade was made on 31 Aug 2016 where Accogli (Giuseppe), the Officer completed a transaction type “Buy” in which 5000 shares were traded at a price of $0.
4 Insider Sales transactions were made totaling 16023 shares traded.
12 analysts projected Price Targets for Baxter International Inc.. The analysts believe that the company stock price could grow as high as $60. The Low Price target projection by analysts is $47 and the Mean Price Target is $52.83.
Baxter International Inc. (NYSE:BAX) has the market capitalization of $26.6 Billion. The company rocked its 52-Week High of $50.16 on Oct 25, 2016 and touched its 52-Week Low of $34.06 on Jan 20, 2016. The stock has Return on Assets (ROA) of 0 percent. Return on Equity (ROE) stands at 0% and Return on Investment (ROI) of 3.4 percent.
The stock is currently showing YTD performance of 24.8 Percent. The company has Beta Value of 0.88 and ATR value of 0.9. The Weekly and Monthly Volatility stands at 2.47% and 1.76%.
Baxter engages in the worldwide development, manufacture and distribution of a diversified line of products, systems and services used primarily in the health-care field. The company’s products are used by hospitals, clinical and medical research laboratories, blood and dialysis centers, rehabilitation centers, nursing homes, doctors’ offices and by patients, at home, under physician supervision.